The cheapest compounded tirzepatide online in September 2026 is $119/month, from Embody and SnagRx, followed by Trimi at $125, Bodybuilding.com Health+ at $174.67, bmiMD at $179, Oak Longevity at $185 and ShedRx at $239. All seven dispense through licensed US pharmacies after a consultation with a US-licensed prescriber, and none charges a separate membership fee. The GLP-1 Price Index snapshot of September 21, 2026 puts the cheapest compounded tirzepatide at $119 and the median across 42 tracked providers at $229/month. Brand-name Zepbound, the same molecule, lists at $1,086/month and runs $299–$449/month self-pay through LillyDirect.
Every price on this page is the standing plan rate each provider leads with on its own site, read by us between September 6 and September 25, 2026; first-month promotions are excluded and the plan term behind each rate is stated. Compounded tirzepatide is not an FDA-approved finished product, and that matters — the section on legality below explains what you are and are not buying.
Quick answer: cheapest compounded tirzepatide, September 2026
| Rank | Provider | Tirzepatide | Plan term behind that rate | Month-to-month | Our rating |
|---|---|---|---|---|---|
| 1 | Embody | $119/mo | 12-month plan ($1,428 billed upfront) | $129 (fall sale; regular $349) | 9.4/10 |
| 1 | SnagRx | $119/mo | 12-month plan, price locked for life | $149/mo | 8.9/10 |
| 3 | Trimi | $125/mo | annual plan ($1,500 billed once) | $235/mo | 9.2/10 |
| 4 | Bodybuilding.com Health+ | $174.67/mo | 6-month bundle | $209/mo | 8.7/10 |
| 5 | bmiMD | $179/mo | 12-month best-value plan | $249/mo | 8.4/10 |
| 6 | Oak Longevity | $185/mo | 12-month plan | not published | 8.9/10 |
| 7 | ShedRx | $239/mo | 12-month plan (2-month minimum on every plan) | $299/mo | 8.8/10 |
Ties are ordered by our rating. Verified but priced above this group: TrimRx at $259/mo (rated 9.3/10, second only to Embody, one flat price at every dose), Enhance MD at $280/mo (labs every six months included), Direct Meds at $297/mo and Sprout Health at $299/mo — the last two carry FDA warning letters, flagged below — and Willow at $399/mo.
What compounded tirzepatide is, and where it stands with the FDA in 2026
Compounded tirzepatide is the same active pharmaceutical ingredient as Eli Lilly's Zepbound and Mounjaro, prepared by a licensed compounding pharmacy — a state-licensed 503A pharmacy filling individual prescriptions, or an FDA-registered 503B outsourcing facility — and supplied in dose-flexible vials rather than Lilly's fixed-dose pens. It is not a generic. The FDA has not reviewed any compounded tirzepatide product for safety, effectiveness or quality, so the manufacturer's finished-product controls that stand behind Zepbound do not apply; quality rests on the individual pharmacy.
The legal footing has narrowed. The FDA took tirzepatide off its drug shortage list in October 2024 and semaglutide in February 2025, ending the shortage-based allowance for copying the brand drugs; the programs still compounding do so under prescriptions for patient-specific formulations. On May 1, 2026 the FDA proposed permanently excluding tirzepatide, semaglutide and liraglutide from the 503B bulk-drug list (the comment period closed June 29, 2026), which would end large-batch 503B compounding if finalized — our 503B explainer tracks it. In September 2025 and February 2026 the FDA also sent warning letters to a run of telehealth sellers, including two on this page, over marketing that called compounded products "the same active ingredient" as the brands; we link each letter on the provider's review page and flag it in every ranking.
What "verified" means for the seven programs above: a US-licensed prescriber reviews you before anything is dispensed, the dispensing pharmacy is a licensed US 503A or 503B facility, the price is published on the provider's own site, and the link we send you to is the one we track and re-check every week. What disqualifies a seller: "research-grade" or "for research use only" tirzepatide (illegal for human use), no prescription step, or imported powder from unverified sources.
The 6 cheapest verified compounded tirzepatide programs (September 2026)
1. Embody — $119/month (cheapest, tied)
Price: $119/month is Embody's 12-month plan price for compounded tirzepatide ($1,428 billed upfront), with no membership fee; the 6- and 3-month plans are $123 and $126/month, and a single month is $129 during Embody's fall sale (regular $349), per joinem.co on September 28, 2026. What's included: licensed physicians, 24/7 specialist messaging, unlimited appointments, a personalized care plan with a metabolic report, free shipping, HSA/FSA eligible, cancel anytime; 48 states. Watch for: month-to-month funnels priced above the headline. Full Embody review.
1. SnagRx — $119/month (cheapest, tied)
Price: $119/month on the 12-month plan, locked in for life so the rate never rises as your dose escalates; month-to-month is $149. What's included: US-licensed clinicians via OpenLoop Health, 1:1 nursing support, prescription review within 24 hours, a LegitScript-certified program dispensing from a US 503A pharmacy, free 1–2 day shipping, a full refund if your prescription is not approved, no membership fee; 48 states. Watch for: the $119 figure needs the 12-month commitment. Full SnagRx review.
3. Trimi — $125/month
Price: $125/month on the annual plan, billed once at $1,500; the 6-month plan is $175/mo, the quarterly plan $199/mo and month-to-month $235/mo. Same price at every dose. What's included: US-licensed clinicians with dose-adjustment support, consultation, prescription, medication and free overnight shipping, no memberships; 47 states. Watch for: a newer program with a short independent track record, and the annual plan is paid up front. Full Trimi review.
4. Bodybuilding.com Health+ — $174.67/month
Price: $174.67/month on the 6-month bundle; 3 months is $179/mo and a single month $209. Its 12-month tier is $187.33/mo, above the 6-month rate, so the 6-month bundle is the one to take. No membership fee. What's included: licensed physicians, telehealth consults, training-aware care plans, microdosing protocols, free shipping; 47 states. Watch for: a newer telehealth arm with a short GLP-1 track record. Full Bodybuilding.com Health+ review.
5. bmiMD — $179/month
Price: $179/month on the 12-month best-value plan; month-to-month is $249. What's included: licensed medical providers, virtual consults, medication and telehealth visits in one price, doorstep delivery, 80,000+ members and a verified 4.4/5 Trustpilot record across 869 reviews. Watch for: GLP-1 is not available in Louisiana or Mississippi, and there is no brand-name pathway. Full bmiMD review.
6. ShedRx (now Shed) — $239/month
Price: $239/month on the 12-month plan; $269 on 6 months and $299 month-to-month, with a 2-month minimum on every plan. What's included: licensed physicians, health coaching, the most delivery forms of any provider, a conditional 120-day guarantee for first-time GLP-1 users, and a brand pathway (Wegovy, Zepbound, Foundayo) under the same account. Watch for: recurring Trustpilot complaints about cancellations, reaching support and unexpected charges. Full ShedRx review.
What does a year of compounded tirzepatide cost?
A year of the cheapest compounded tirzepatide costs $1,428 at Embody or SnagRx, against $3,588–$5,388 for Zepbound through LillyDirect and $13,032 at list price.
| Option | Monthly | 12 months | Plan term | FDA status |
|---|---|---|---|---|
| Embody compounded tirzepatide | $119 | $1,428 | 12-month plan | compounded, not FDA-approved |
| SnagRx compounded tirzepatide | $119 | $1,428 | 12-month plan | compounded, not FDA-approved |
| Trimi compounded tirzepatide | $125 | $1,500 | annual, billed once | compounded, not FDA-approved |
| Bodybuilding.com Health+ | $174.67 | $2,096 (two 6-month bundles) | 6-month bundle | compounded, not FDA-approved |
| bmiMD compounded tirzepatide | $179 | $2,148 | 12-month plan | compounded, not FDA-approved |
| Oak Longevity compounded tirzepatide | $185 | $2,220 | 12-month plan | compounded, not FDA-approved |
| ShedRx compounded tirzepatide | $239 | $2,868 | 12-month plan | compounded, not FDA-approved |
| TrimRx compounded tirzepatide | $259 | $3,108 | flat at every dose | compounded, not FDA-approved |
| Zepbound via LillyDirect (self-pay) | $299–$449 by dose | $3,588–$5,388 | 45-day refill rule for the $449 tier | FDA-approved |
| Zepbound with commercial coverage + savings card | as low as $25 | $300 | up to 13 fills/year | FDA-approved |
| Zepbound on the Medicare GLP-1 Bridge | $50 | $600 | KwikPen only, three BMI tiers | FDA-approved |
| Zepbound at list price | $1,086 | $13,032 | retail | FDA-approved |
How compounded tirzepatide compares to Zepbound
Zepbound is the FDA-approved product. Its list price is $1,086/month at every dose; Lilly's own self-pay channel, LillyDirect, sells vials and KwikPens at $299 (2.5 mg), $399 (5 mg) and $449 (7.5–15 mg, when refilled within 45 days); commercially insured patients whose plans cover it pay as little as $25 with the savings card; and eligible Medicare Part D enrollees pay $50/month for the KwikPen under the GLP-1 Bridge. Every path is detailed on our Zepbound cost page.
The clinical evidence belongs to the brand. In SURMOUNT-1 (*New England Journal of Medicine*, 2022), adults on 15 mg of Zepbound lost an average of 20.9% of body weight over 72 weeks, and the SURMOUNT-5 head-to-head put tirzepatide ahead of semaglutide, 20.2% versus 13.7% — our semaglutide vs tirzepatide comparison covers it. Compounded tirzepatide has no trial of its own. It is the same molecule, so prescribers expect similar effects at the same dose, but that expectation rests on the pharmacy's quality, not on FDA review.
So the honest framing is a trade: the cheapest compounded program costs $1,428 a year against $3,588–$5,388 for LillyDirect Zepbound, a gap of $2,160–$3,960, in exchange for giving up the approved finished product. If your insurance covers Zepbound or you qualify for the Medicare Bridge, the brand is cheaper than every program on this page.
What should you check before buying compounded tirzepatide online?
Five things, in this order: the plan term behind the price, who prescribes and which pharmacy dispenses, whether the product is 503A or 503B, the provider's FDA record, and the price at the dose you will actually take.
1. Get the plan term in writing. The $119 and $125 rates are annual or 12-month figures; ask what is charged today, what the next charge is and when, and what happens to a prepaid balance if you stop. 2. Confirm who prescribes and which pharmacy dispenses, and that both are licensed for your state; the provider should name them without hesitation. 3. Ask whether the product is 503A or 503B and how the pharmacy sources its tirzepatide. Never buy anything labelled "research use only". 4. Check the FDA record. Two programs listed on this page — Sprout Health (letter, September 9, 2025) and Direct Meds (letter, September 9, 2025) — were warned over "same active ingredient" marketing claims; the letters concern claims, not patient harm, and we disclose them on every ranking. 5. Price the dose you will actually take. Flat-price programs (SnagRx, Trimi, TrimRx) cost the same at 15 mg as at 2.5 mg; check whether yours does.
Which compounded tirzepatide program should you choose?
Embody or SnagRx at $119 if price decides it, Trimi at $125 if you would rather pay once a year, TrimRx at $259 if you want the deepest clinical support, and none of them if insurance or Medicare covers Zepbound.
- Lowest price and you will stay on it: Embody or SnagRx at $119 — SnagRx if you want the rate locked for the full year, Embody if you want month-to-month flexibility and can confirm the checkout rate.
- Lowest price paid once a year: Trimi at $125 on the $1,500 annual plan.
- Strongest clinical wrap: TrimRx at $259 — rated 9.3/10, flat at every dose, with unlimited check-ins.
- A brand-name fallback under the same account: ShedRx, which sells Zepbound and Wegovy alongside its compounded plans.
- Insurance covers Zepbound, or you are on Medicare: skip compounded — the $25 savings card or the $50 Bridge beats all of the above.
Compare the other molecule in our cheapest compounded semaglutide ranking, or every tracked program on the cheapest GLP-1 programs page.
FAQ
What is the cheapest compounded tirzepatide online? $119 per month, from Embody (12-month plan) and SnagRx (12-month plan, locked for life), as of September 2026. Trimi is next at $125 on an annual plan, then Bodybuilding.com Health+ at $174.67, bmiMD at $179 and ShedRx at $239. The GLP-1 Price Index median across 42 tracked providers is $229/month.
Is compounded tirzepatide legal in 2026? It can be prescribed and dispensed by licensed 503A pharmacies and 503B outsourcing facilities for patient-specific prescriptions, but it is not FDA-approved and the room to compound it has narrowed since the FDA ended the tirzepatide shortage in October 2024. The FDA's May 1, 2026 proposal to exclude it from the 503B bulk-drug list would restrict large-batch compounding further if finalized.
Is compounded tirzepatide the same as Zepbound? It contains the same active molecule, tirzepatide, but it is not the same product: Zepbound is an FDA-approved finished drug with Lilly's manufacturing controls and the SURMOUNT trial data behind it, while a compounded preparation is made by an individual pharmacy without FDA review. Prescribers expect similar effects at the same dose; the difference is who stands behind the quality.
Why is the $119 price tied to a 12-month plan? Because the cheapest rates are the longest commitments: SnagRx's $119 needs a 12-month plan (month-to-month is $149), Trimi's $125 is an annual plan billed at $1,500 once, and bmiMD's $179 is a 12-month rate ($249 monthly). Embody's $119 is its advertised starting rate; some checkout funnels quote about $149 month-to-month. Always price the term you will actually keep.
How much does compounded tirzepatide cost per month on average? $229 per month is the median across the 42 compounded providers in our GLP-1 Price Index snapshot of September 21, 2026, with a floor of $119 and tracked programs running up to $399. The median has fallen from $249 in mid-August 2026.
Is compounded tirzepatide safe? Safety depends on the pharmacy, because there is no FDA review of the finished product. Use a program that names its licensed prescriber and its 503A or 503B pharmacy, avoid anything sold for "research use only", and read the FDA warning letters we flag on two of the programs above; they concern marketing claims, but they tell you how a company handles the rules. Our compounded semaglutide safety guide covers the same ground for both molecules.
Which compounded tirzepatide provider is highest rated? Embody, at 9.4/10 in our review, which is also the cheapest at $119/month. TrimRx is next at 9.3/10 ($259/month, flat at every dose), then Trimi at 9.2/10 ($125 on its annual plan); among the seven cheapest programs the next-highest are SnagRx and Oak Longevity (8.9 each) and ShedRx (8.8).